ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Arkansas » Internal Medicine

Top Internal Medicine Prescribers in Arkansas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ABSALOM TILLEY M.D.

Internal Medicine

33,922

$1.66M

905
532 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $53

BEN OWENS MD

Internal Medicine

33,633

$1.61M

1040
811 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $53

SHALENDER MITTAL M.D.

Internal Medicine

27,662

$903K

636
482 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 23%

$33
Average prescription price

Avg: $53

TOMMY LOVE MD

Internal Medicine

26,001

$1.19M

807
545 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $53

MARK WOOD M.D.

Internal Medicine

25,937

$1.36M

635
510 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $53

SUDHIR KUMAR M.D.

Internal Medicine

24,729

$1.11M

748
535 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

24%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $53

COREY DIAMOND MD

Internal Medicine

24,452

$1.18M

797
612 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $53

REVEL PORTER MD

Internal Medicine

23,513

$1.39M

741
581 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $53

CHARLES KLEPPER M.D.

Internal Medicine

23,458

$874K

824
597 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 23%

$37
Average prescription price

Avg: $53

LANCE HAMILTON M.D.

Internal Medicine

22,510

$1.32M

805
632 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $53

DONALD GUINN MD

Internal Medicine

21,783

$921K

713
570 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $53

GARY GEHRKI M.D.

Internal Medicine

20,765

$990K

611
290 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

30%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $53

FRED MURPHY MD

Internal Medicine

20,626

$1.05M

634
522 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $53

BRANNON TREECE MD

Internal Medicine

20,513

$1.27M

638
476 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $53

STEPHEN WOODRUFF M.D.

Internal Medicine

19,815

$1.06M

639
565 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $53

JOSEPH DELUCA MD

Internal Medicine

19,757

$885K

625
459 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $53

HOMER BEAVERS MD

Internal Medicine

19,535

$868K

646
507 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

26%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $53

JOHN AGENT DO

Internal Medicine

19,456

$1.22M

780
614 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $53

JOSEPH KULPEKSA M.D.

Internal Medicine

19,398

$914K

653
394 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

30%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $53

PAUL VELLOZO MD

Internal Medicine

18,040

$802K

499
393 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

21%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $53

MOHSEN KEYASHIAN MD

Internal Medicine

17,807

$821K

783
663 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $53

LANCE LINCOLN M.D.

Internal Medicine

17,098

$923K

845
654 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $53

CHING-SHAN LIN MD

Internal Medicine

16,367

$823K

482
360 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $53

ROBERT DORMAN MD

Internal Medicine

16,316

$660K

475
326 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $53

SUDESH BANAJI M.D

Internal Medicine

16,312

$797K

494
361 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $53

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank